These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2174306)

  • 1. Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP.
    Leeuwenkamp OR; van der Vijgh WJ; Neijt JP; Pinedo HM
    Cancer Chemother Pharmacol; 1990; 27(2):111-4. PubMed ID: 2174306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.
    Leeuwenkamp OR; Neijt JP; van der Vijgh WJ; Pinedo HM
    Eur J Cancer; 1991; 27(10):1243-7. PubMed ID: 1835593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
    Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin.
    Goel R; Cleary SM; Horton C; Kirmani S; Abramson I; Kelly C; Howell SB
    J Natl Cancer Inst; 1989 Oct; 81(20):1552-60. PubMed ID: 2552131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
    Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
    Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.
    Goel R; Andrews PA; Pfeifle CE; Abramson IS; Kirmani S; Howell SB
    Eur J Cancer; 1990 Jan; 26(1):21-7. PubMed ID: 2156545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
    Howell SB; Pfeifle CE; Wung WE; Olshen RA
    Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K; Siddik ZH; Khokhar AR; al-Baker S; Sampedro F; Perez-Soler R
    Cancer Chemother Pharmacol; 1992; 30(5):365-9. PubMed ID: 1505075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic behaviour of cisplatin in peritoneal fluid after intraperitoneal administration of cisplatin-loaded microspheres.
    Tamura T; Imai J; Matsukawa Y; Horikiri Y; Suzuki T; Yoshino H; Ike O
    J Pharm Pharmacol; 2001 Oct; 53(10):1331-9. PubMed ID: 11697540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS; Riviere JE
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
    Hayata S; Hitoshi T; Kiyokawa K; Esaki S; Mihashi S; Hirano M
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2356-61. PubMed ID: 6541891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats.
    Verschraagen M; Boven E; Torun E; Erkelens CA; Hausheer FH; van der Vijgh WJ
    Br J Cancer; 2004 Apr; 90(8):1654-9. PubMed ID: 15083199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective treatment of peritoneal carcinosis by intraperitoneal cis-diamminedichloroplatinum (c-DDP) administration with systemic sodium thiosulfate protection. Clinical results and pharmacokinetics].
    Rückle H; Ehninger G; Jakob F; Wilms K
    Klin Wochenschr; 1986 May; 64(10):467-74. PubMed ID: 3723994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
    Wagner T; Kreft B; Bohlmann G; Schwieder G
    J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients.
    Nagai N; Kinoshita M; Ogata H; Tsujino D; Wada Y; Someya K; Ohno T; Masuhara K; Tanaka Y; Kato K; Nagai H; Yokoyama A; Kurita Y
    Cancer Chemother Pharmacol; 1996; 39(1-2):131-7. PubMed ID: 8995510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer].
    Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.
    Treskes M; Holwerda U; Klein I; Pinedo HM; van der Vijgh WJ
    Biochem Pharmacol; 1991 Nov; 42(11):2125-30. PubMed ID: 1659819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.